Cargando…
A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia
Pyruvate kinase M2 isoform (PKM2), a rate-limiting enzyme in the final step of glycolysis, is known to be associated with the metabolic rewiring of cancer cells, and considered an important cancer therapeutic target. Herein, we report a novel PKM2 activator, PA-12, which was identified via the molec...
Autores principales: | Kim, Dong Joon, Park, Young Soo, Kim, Nam Doo, Min, Sang Hyun, You, Yeon-Mi, Jung, Yuri, Koo, Han, Noh, Hanmi, Kim, Jung-Ae, Park, Kyung Chan, Yeom, Young Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400313/ https://www.ncbi.nlm.nih.gov/pubmed/25813626 http://dx.doi.org/10.14348/molcells.2015.2314 |
Ejemplares similares
-
Pyruvate dehydrogenase kinase regulates hepatitis C virus replication
por: Jung, Gwon-Soo, et al.
Publicado: (2016) -
AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth
por: Park, Young Soo, et al.
Publicado: (2016) -
PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia
por: Koo, Han, et al.
Publicado: (2021) -
Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation
por: Lee, Sun Joo, et al.
Publicado: (2015) -
Metabolic Signaling to Epigenetic Alterations in Cancer
por: Kim, Jung-Ae, et al.
Publicado: (2018)